Form 4: West Pharmaceutical Services Director Acquires and Disposes of Shares

Director Paolo Pucci reports changes in beneficial ownership of West Pharmaceutical Services Inc. stock, including acquisition of restricted stock units and disposal of shares.

Summary

• On April 23, 2024, Paolo Pucci, a director of West Pharmaceutical Services Inc., acquired 564 shares of common stock.
• These shares were acquired as restricted stock units, which will vest in full at the next annual shareholder meeting.
• The shares are distributable under the terms of the Deferred Compensation Plan for Outside Directors.
• On the same day, Pucci disposed of 9,875.95 shares of common stock.
• Following these transactions, Pucci's beneficially owned shares amount to 9,875.95.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by a company director, indicating a neutral sentiment.

Future Outlook

The restricted stock units will vest in full at the next annual shareholder meeting.

Industry Context

Form 4 filings are standard disclosures required by the SEC to ensure transparency in trading activities by company insiders.

Stakeholder Impact

• The transactions may be of interest to shareholders as they provide insight into the actions of company leadership.

Next Steps

• The restricted stock units will vest at the next annual shareholder meeting.

Key Dates